# BioSight

BioSight is an Asset Manager based in Herzliya, Israel.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Herzliya, Israel
- **Region:** Middle East
- **Address:** Herzliya, Israel
- **Assets under management:** Undisclosed
- **Website:** biosight-pharma.com

## Regulatory record

- **Reports private funds:** No

## About

BioSight is a pharmaceutical development company, developing novel cancer-targeted drugs. BioSight

## Sectors

- Healthcare Services

## Questions

### Are there other drugs in BioSight's pipeline?

No other drug candidates are disclosed on BioSight's website as of the latest available information. The firm's public corporate profile is built entirely around the advancement of BST-236, positioning it as a single-asset pharmaceutical developer.

### Who founded BioSight, and who runs the company?

BioSight does not publicly identify its founders, management team, or board of directors on its primary website. The firm operates without a public-facing executive leadership page, making the identity of key investment and scientific decision-makers unavailable from primary sources.

## Related profiles

- [Chemonics International](https://altss.com/profile/chemonics-international-inc)
- [Aurora Payments](https://altss.com/profile/aurora-payments-llc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/biosight-ltd

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology